199 related articles for article (PubMed ID: 12170469)
21. [Detection of sperm chromosomes in Robertsonian translocation carriers by dual-color fluorescence in situ hybridization].
Liu Y; Zhu H
Zhonghua Nan Ke Xue; 2004 Feb; 10(2):90-3. PubMed ID: 15027178
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the recurrent translocation t(1;1)(p36.3;q21.1-2) in non-Hodgkin lymphoma by multicolor banding and fluorescence in situ hybridization analysis.
Lestou VS; Ludkovski O; Connors JM; Gascoyne RD; Lam WL; Horsman DE
Genes Chromosomes Cancer; 2003 Apr; 36(4):375-81. PubMed ID: 12619161
[TBL] [Abstract][Full Text] [Related]
23. A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndrome.
Odero MD; Vizmanos JL; Román JP; Lahortiga I; Panizo C; Calasanz MJ; Zeleznik-Le NJ; Rowley JD; Novo FJ
Genes Chromosomes Cancer; 2002 Sep; 35(1):11-9. PubMed ID: 12203785
[TBL] [Abstract][Full Text] [Related]
24. [Interphasic in situ fluorescent hybridization (FISH) in 4 cases of myeloid neoplasias with chromosome 7 changes].
Arranz E; Renedo M; Ramos C; Martínez B; Prieto E; Benítez J
Sangre (Barc); 1994 Dec; 39(6):457-60. PubMed ID: 7855698
[TBL] [Abstract][Full Text] [Related]
25. A patient with myelodysplastic syndrome studied by GTG-banding and fluorescent in situ hybridization (FISH).
Mark HF; Mark Y; Sotomayor E; Sambandam S
Cytobios; 1998; 94(376):121-8. PubMed ID: 9839434
[TBL] [Abstract][Full Text] [Related]
26. [Study of a familial insertional translocation involving chromosomes 1 and 7 by using fluorescence in situ hybridization].
Tan Y; Li X; Li L; Lu G
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Jun; 18(3):183-6. PubMed ID: 11402445
[TBL] [Abstract][Full Text] [Related]
27. Chromosomal changes detected by fluorescence in situ hybridization in patients with acute lymphoblastic leukemia.
Zhang L; Parkhurst JB; Kern WF; Scott KV; Niccum D; Mulvihill JJ; Li S
Chin Med J (Engl); 2003 Sep; 116(9):1298-303. PubMed ID: 14527352
[TBL] [Abstract][Full Text] [Related]
28. [Clinical and molecular cytogenetic features of myeloid diseases characterized by i(20q-): a study of seven cases].
Li TY; Xue YQ; Wu YF; Pan JL; Liu DD; Gong SL
Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):732-5. PubMed ID: 15200909
[TBL] [Abstract][Full Text] [Related]
29. [Analysis the clinic and cytogenetics of myelodysplastic syndrome].
Cen L; Zhou M; Zhao YH
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):668-9. PubMed ID: 17160950
[TBL] [Abstract][Full Text] [Related]
30. [Clinical and laboratory characteristics of two acute lymphoblastic leukemia patients with dicentric (9; 20) (p11 - 13; q11)].
Gong SL; Qiu HY; Li JY; Han FL; Song XM; Huang ZX; Wang JM
Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):306-9. PubMed ID: 16875578
[TBL] [Abstract][Full Text] [Related]
31. Quantifying chromosome changes and lineage involvement in myelodysplastic syndrome (MDS) using fluorescent in situ hybridization (FISH).
Han K; Lee W; Harris CP; Kim W; Shim S; Meisner LF
Leukemia; 1994 Jan; 8(1):81-6. PubMed ID: 8289503
[TBL] [Abstract][Full Text] [Related]
32. Investigation of bone marrow involvement in malignant lymphoma using fluorescence in situ hybridization: possible utility in the detection of micrometastasis.
Huh HJ; Min HC; Cho HI; Chae SL; Lee DS
Cancer Genet Cytogenet; 2008 Oct; 186(1):1-5. PubMed ID: 18786435
[TBL] [Abstract][Full Text] [Related]
33. Gain of 1q in pediatric myelodysplastic syndromes.
Morerio C; Rapella A; Tassano E; Lanino E; Micalizzi C; Rosanda C; Panarello C
Leuk Res; 2006 Nov; 30(11):1437-41. PubMed ID: 16472857
[TBL] [Abstract][Full Text] [Related]
34. [Molecular cytogenetic analysis of -7/7q- abnormalities in patients with myeloid malignancies].
Xiao Y; Liu SH; Liu XP; Qin S; Bo LJ; Li CW; Dai Y; Wang JS
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):471-6. PubMed ID: 14669212
[TBL] [Abstract][Full Text] [Related]
35. Cytogenetics and fluorescence in-situ hybridization in detection of hematological malignancies.
Frenny VJ; Antonella Z; Luisa A; Shah AD; Sheth JJ; Rocchi M
Indian J Cancer; 2003; 40(4):135-9. PubMed ID: 14716109
[TBL] [Abstract][Full Text] [Related]
36. [Fluorescence in situ hybridization studies on a myeloid leukemia patient with ins(8;21)(q22;q22.1q22.3)].
Wu YF; Xue YQ; Bai SX; Zhang J; Yao L; Wang Y; Qiu HY; Shen J; Pan JL; Ma QF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):203-6. PubMed ID: 19350517
[TBL] [Abstract][Full Text] [Related]
37. [Application of dual-color fluorescence in situ hybridization in acute myeloid leukemia with t (8; 21)].
Li CW; Bo LJ; Dai Y; Liu XP; Qin S; Liu SH; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2006 Jan; 27(1):32-5. PubMed ID: 16732938
[TBL] [Abstract][Full Text] [Related]
38. Centromeric breakage and highly rearranged chromosome derivatives associated with mutations of TP53 are common in therapy-related MDS and AML after therapy with alkylating agents: an M-FISH study.
Andersen MK; Christiansen DH; Pedersen-Bjergaard J
Genes Chromosomes Cancer; 2005 Apr; 42(4):358-71. PubMed ID: 15645489
[TBL] [Abstract][Full Text] [Related]
39. [A dual-color fluorescence in situ hybridization study on the detection of inv(16) in acute myeloid leukemia].
Li M; Xue YQ; Wu YF; Pan JL; Yao L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Aug; 20(4):331-5. PubMed ID: 12903046
[TBL] [Abstract][Full Text] [Related]
40. Shwachman syndrome as mutator phenotype responsible for myeloid dysplasia/neoplasia through karyotype instability and chromosomes 7 and 20 anomalies.
Maserati E; Minelli A; Pressato B; Valli R; Crescenzi B; Stefanelli M; Menna G; Sainati L; Poli F; Panarello C; Zecca M; Curto FL; Mecucci C; Danesino C; Pasquali F
Genes Chromosomes Cancer; 2006 Apr; 45(4):375-82. PubMed ID: 16382447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
